Volume 3•Issue 1

Sean R Tunis is the founder, President and Chief Executive Officer of the Center for Medical Technology Policy in Baltimore (MD, USA). The Center for Medical Technology Policy‘s main objective is to improve the quality, relevance and efficiency of ...

Aims: To provide evidence on the comparative effectiveness of oral diabetes drug combinations. Methods: We performed a retrospective, observational cohort study of glycosylated hemoglobin change in outpatients newly exposed to dual- or triple-drug oral ...

Background: Generic losartan provides an opportunity to enhance angiotensin receptor blocker (ARB) prescribing efficiency, with all ARBs essentially being similar. Initially, there was limited activity in NHS Bury (UK). This changed in March 2011 with ...

Economic modeling has rarely been considered to be an essential component of healthcare policy-making in the USA, due to a lack of transparency in model design and assumptions, as well as political interests that equate examination of cost with unfair ...

Propensity score (PS) methods have proliferated in recent years in observational studies in general and in observational comparative effectiveness research (CER) in particular. PS methods are an important set of tools for estimating treatment effects in ...

The scope of comparative effectiveness research (CER) is wide and therefore requires the application of complex statistical tools and nonstandard procedures. The commonly used methods presuppose the realization of important, and often untestable, ...

Follicular lymphoma (FL) is the most common indolent non-Hodgkin’s lymphoma in northern America. FL is an incurable disease with relapsing–remitting courses requiring serial intermittent treatments. Duration of remission will often become progressively ...